检索结果 - Bodegard, Johan

Refine Results
  1. 1
    Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients

    Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients 由 Carlborg, Andreas, Thuresson, Marcus, Ferntoft, Lena, Bodegard, Johan

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

    Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type... 由 Nyström, Thomas, Bodegard, Johan, Nathanson, David, Thuresson, Marcus, Norhammar, Anna, Eriksson, Jan W.

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study

    Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study... 由 Norhammar, Anna, Bodegård, Johan, Nyström, Thomas, Thuresson, Marcus, Nathanson, David, Eriksson, Jan W.

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan

    Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan 由 Russell, David, Stålhammar, Jan, Bodegard, Johan, Hasvold, Pål, Thuresson, Marcus, Kjeldsen, Sverre E.

    出版 2010
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men

    Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men 由 Farkhooy, Amir, Bodegård, Johan, Erikssen, Jan Erik, Janson, Christer, Hedenström, Hans, Stavem, Knut, Malinovschi, Andrei

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

    Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014 由 Nathanson, David, Sabale, Ugne, Eriksson, Jan W., Nyström, Thomas, Norhammar, Anna, Olsson, Urban, Bodegård, Johan

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study

    Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide obse... 由 Norhammar, Anna, Bodegard, Johan, Nyström, Thomas, Thuresson, Marcus, Rikner, Klas, Nathanson, David, Eriksson, Jan W.

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  8. 8
    Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

    Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study 由 Grundvold, Irene, Bodegard, Johan, Nilsson, Peter M, Svennblad, Bodil, Johansson, Gunnar, Östgren, Carl Johan, Sundström, Johan

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  9. 9
    Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study

    Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study 由 Kohsaka, Shun, Takeda, Masayoshi, Bodegård, Johan, Thuresson, Marcus, Kosiborod, Mikhail, Yajima, Toshitaka, Wittbrodt, Eric, Fenici, Peter

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  10. 10
    Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting

    Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting 由 Hasvold, Pål, Thuresson, Marcus, Sundström, Johan, Hammar, Niklas, Kjeldsen, Sverre E., Johansson, Gunnar, Holme, Ingar, Bodegård, Johan

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  11. 11
    Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

    Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study 由 Kristófi, Robin, Bodegard, Johan, Norhammar, Anna, Thuresson, Marcus, Nathanson, David, Nyström, Thomas, Birkeland, Kåre I., Eriksson, Jan W.

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  12. 12
    Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational study

    Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational study 由 Jernberg, Tomas, Lindholm, Daniel, Hasvold, Lars Pål, Svennblad, Bodil, Bodegård, Johan, Sundell Andersson, Karolina, Thuresson, Marcus, Erlinge, David, Janzon, Magnus

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  13. 13
    Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle‐Aged Men: a 28‐Year Follow‐Up Study

    Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle‐Aged Men: a 28‐Year Follow‐Up Study 由 Engeseth, Kristian, Hodnesdal, Christian, Grundvold, Irene, Liestøl, Knut, Gjesdal, Knut, Kjeldsen, Sverre E., Erikssen, Jan E., Bodegard, Johan, Skretteberg, Per Torger

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  14. 14
    How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

    How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study 由 Birkeland, Kåre I., Bodegard, Johan, Norhammar, Anna, Kuiper, Josephina G., Georgiado, Elena, Beekman‐Hendriks, Wendy L., Thuresson, Marcus, Pignot, Marc, Herings, Ron M. C., Kooy, Adriaan

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  15. 15
    Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults

    Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults 由 Schechter, Meir, Melzer Cohen, Cheli, Yanuv, Ilan, Rozenberg, Aliza, Chodick, Gabriel, Bodegård, Johan, Leiter, Lawrence A., Verma, Subodh, Lambers Heerspink, Hiddo J., Karasik, Avraham, Mosenzon, Ofri

    出版 2022
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  16. 16
    Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

    Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidas... 由 Persson, Frederik, Nyström, Thomas, Jørgensen, Marit E., Carstensen, Bendix, Gulseth, Hanne L., Thuresson, Marcus, Fenici, Peter, Nathanson, David, Eriksson, Jan W., Norhammar, Anna, Bodegard, Johan, Birkeland, Kåre I.

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  17. 17
    Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

    Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effect... 由 Kosiborod, Mikhail, Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Birkeland, Kåre I., Jørgensen, Marit Eika, Thuresson, Marcus, Arya, Niki, Bodegård, Johan, Hammar, Niklas, Fenici, Peter

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  18. 18
    Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

    Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from... 由 Kosiborod, Mikhail, Birkeland, Kåre I., Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Jørgensen, Marit E., Wittbrodt, Eric T., Thuresson, Marcus, Bodegård, Johan, Hammar, Niklas, Fenici, Peter

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  19. 19
    Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study

    Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study... 由 Persson, Frederik, Bodegard, Johan, Lahtela, Jorma T., Nyström, Thomas, Jørgensen, Marit E., Jensen, Majken Linneman, Gulseth, Hanne L., Thuresson, Marcus, Hoti, Fabian, Nathanson, David, Norhammar, Anna, Birkeland, Kåre I., Eriksson, Johan G., Eriksson, Jan W.

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  20. 20
    Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

    Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal dis... 由 Birkeland, Kåre I., Bodegard, Johan, Banerjee, Amitava, Kim, Dae Jung, Norhammar, Anna, Eriksson, Jan W., Thuresson, Marcus, Okami, Suguru, Ha, Kyoung Hwa, Kossack, Nils, Mamza, Jil Billy, Zhang, Ruiqi, Yajima, Toshitaka, Komuro, Issei, Kadowaki, Takashi

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: